|
|
|
|
Welcome to Validation Week 2008
FDA Presentation

FDA's Risk-Based Inspection Model: A Year in Review at the Field Office Level Karyn M. Campbell, Acting Director, Investigations Branch, U.S. Food and Drug Administration
Create Your Own Event with 39 Interactive Sessions and Workshops:
- Build Roadmaps for Effective Process, Cleaning and Compuer Validation
- Audit and Train Suppliers on Validation Principles
- Benchmark from Validation Implementation Case Studies on Six Sigma, Utilities, Global Networking, Personnel Training, FMEA, and Many More!
- Ensure Your Facilities and Equipment are Qualified
- Hear New Regulatory Updates on FDA's Update to the 1987 Guidance to Industry on Process Validation, ASTM E2500, ICH, and Other Global Agencies
- Learn How to Write Exceptional Validation Protocols
- Establish Effective Acceptance Criteria for Process Validation
- Handle Deviations and Risk During Validation
Benchmark and Learn From Your Peers!
- Pfizer, Inc.
- Wyeth Research
- Purdue Pharmaceuticals
- U.S. FDA
- Vertex Pharmaceuticals
- Abbott Vascular
- Amgen
- Schering-Plough
- Roche Professional Diagnostics
- GlaxoSmithKline, Biopharmaceutical CEDD
- Nektar Therapeutics
|
|
|
|
|
|
|
|